Clinical TrialsSearch results
Number of results: 242
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- JBCRG-M06(EMERALD)
- HER2-positive progressive-recurrent breast cancer
- Yamashita Toshinari
- 2019-03-25
Recruiting
- JESS14
- Ewing sarcoma family tumor
- Sano Hideki
- 2019-03-25
Completed
- Clinical application of chest x-ray dynamic photography
- chest trauma
- SHIMADA JIRO
- 2019-03-25
Completed
- JBCRG-M04 (BOOSTER)
- Hormone receptor positive, HER2 negative advanced or recurrence (metastatic) breast cancer
- Saji Shigehira
- 2019-03-25
Completed
- JBCRG-M07(FUTURE)
- advanced or metastatic HR-positive HER2-negative breast cancer
- Watanabe Ken-ichi
- 2019-03-25
Completed
- Clinical application of chest x-ray dynamic photography
- pulmonary embolism
- SHIMADA JIRO
- 2019-03-15
Completed
- Combination of checkpoint inhibitor and radiotherapy for re-current gastric cancer after initial treatment with standard therapy.
- Gastric cancer
- Kono Koji
- 2018-12-10
Other
- Phase II study of irinotecan and tegafur gimeracil for NSCLC with EGFR mutation which resistant to EGFR-TKI
- Non-small-cell lung cancer
- North Japan Lung Cancer Study Group
- 2010-08-31
Other
- Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer
- Small-cell lung cancer
- Tohoku University Hospital
- 2010-03-31
Other
- Phase II study of amrubicin combined with carboplatin for unresectable invasive thymoma or thymic carcinoma
- Thymoma/Thymic carcinoma
- Tohoku University Hospital
- 2010-03-31